Everyday over 100 million Americans use some form of calorie-counting applications to live a healthier life, but current solutions require tedious, manual data entry which is time consuming, frustrating, and worst of all inaccurate. SmartPlate is the world’s first connected plate that instantly analyzes everything people eat with up to 99% accuracy. Their patent-pending technology deploys advanced object recognition and load sensors to identify & weigh food within seconds. SmartPlate is poised to replace manual calorie-counting apps, improving the efficiency of meal-tracking by 80%. They believe that SmartPlate is a crucial accountability tool to help people manage their diets, whether their aim is to lose weight, improve their athletic performance, or manage a chronic illness. SmartPlate is backed by Penn Medicine, Independence Blue Cross, University City Science Center, Digital Health Accelerator and DreamIt Health.

Everyday over 100 million Americans use some form of calorie-counting applications to live a healthier life, but current solutions require tedious, manual data entry which is time consuming, frustrating, and worst of all inaccurate. SmartPlate is the world’s first connected plate that instantly analyzes everything people eat with up to 99% accuracy. Their patent-pending technology deploys advanced object recognition and load sensors to identify & weigh food within seconds. SmartPlate is poised to replace manual calorie-counting apps, improving the efficiency of meal-tracking by 80%. They believe that SmartPlate is a crucial accountability tool to help people manage their diets, whether their aim is to lose weight, improve their athletic performance, or manage a chronic illness. SmartPlate is backed by Penn Medicine, Independence Blue Cross, University City Science Center, Digital Health Accelerator and DreamIt Health.

DayTwo provides personalized nutrition and actionable insights that allow consumers to live healthier and maintain normal blood sugar levels. DayTwo does this through DNA sequencing of the gut microbiome – the vast collection of bacteria, which is as unique to each individual as their fingerprints. DayTwo leverages the scientific and evidence-based understanding of the microbiome so consumers may take practical and immediate steps to improve their own health and wellbeing. The DayTwo service is based on six years of clinical research conducted by Professors Eran Segal and Dr. Eran Elinav from the Weizmann Institute of Science in Israel. Dr. Segal’s and Dr. Elinav’s research has been funded solely by the Weizmann Institute of Science and upon its completion, the research technology was licensed exclusively to DayTwo. The clincial research results on which our product and service is based have been published in the Nature, The Cell, Cell Metabolism.

DayTwo provides personalized nutrition and actionable insights that allow consumers to live healthier and maintain normal blood sugar levels. DayTwo does this through DNA sequencing of the gut microbiome – the vast collection of bacteria, which is as unique to each individual as their fingerprints. DayTwo leverages the scientific and evidence-based understanding of the microbiome so consumers may take practical and immediate steps to improve their own health and wellbeing. The DayTwo service is based on six years of clinical research conducted by Professors Eran Segal and Dr. Eran Elinav from the Weizmann Institute of Science in Israel. Dr. Segal’s and Dr. Elinav’s research has been funded solely by the Weizmann Institute of Science and upon its completion, the research technology was licensed exclusively to DayTwo. The clincial research results on which our product and service is based have been published in the Nature, The Cell, Cell Metabolism.